Navigation Links
Labopharm Reports Results for First Quarter Fiscal 2009
Date:5/7/2009

1,061 ------------------------------------------------------------------------- 4,957 3,219 ------------------------------------------------------------------------- EXPENSES Cost of goods sold (excluding amortization) 1,393 951 Research and development expenses, net 4,027 5,691 Selling, general and administrative expenses 6,724 4,907 Financial expenses 1,014 711 Impairment loss on long-term investment - 691 Depreciation and amortization 463 485 Interest income (187) (652) Foreign exchange gain (503) (272) ------------------------------------------------------------------------- 12,931 12,512 ------------------------------------------------------------------------- Loss before income taxes (7,974) (9,293) Provision for income taxes Current - 450 ------------------------------------------------------------------------- Net loss for the period (7,974) (9,743) ------------------------------------------------------------------------- ------------------------------------------------------------------------- Net loss per share - basic and diluted (0.14) (0.17) ------------------------------------------------------------------------- ------------------------------------------------------------------------- Weighted average number of common shares outstanding 56,826,148 56,818,187
'/>"/>
SOURCE Labopharm Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related medicine news :

1. Labopharm To Present Poster On Onset Of Analgesic Effect Of Once-Daily Tramadol At Congress Of The European Society Of Regional Anaesthesia And Pain Therapy
2. Labopharm provides update on U.S. regulatory process for once-daily Tramadol
3. Labopharm completes enrolment for Phase III clinical study for its once-daily trazodone antidepressant drug
4. Labopharm appeals FDAs decision on once-daily tramadol
5. Labopharm to host conference call Friday, November 9, 2007 at 8:30 a.m. (ET)
6. Labopharm to present at CIBC World Markets 18th Annual Healthcare Conference
7. Labopharm Reports Results for Third Quarter Fiscal 2007
8. Labopharm receives FDA response to appeal of Approvable Letter for once-daily tramadol
9. Labopharm enters into licensing and distribution agreement for once-daily tramadol in Australia with iNova
10. Canadian Marketing and Sales Effort for Labopharms Once-Daily Tramadol Product to Expand Significantly
11. Labopharm Reports Positive Results for Phase III Study on Once-daily Trazodone
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/17/2014)... No matter how far modern medicine advances, it ... louse parasite—a common childhood malady and a source of ... and twelve million individuals will suffer an infestation. ... comes to the rescue, providing an all-natural treatment that ... record of customer service, and effectiveness in getting rid ...
(Date:12/17/2014)... 15, 2014 (HealthDay News) -- As gas prices rose ... a new study suggests. In times of gas ... those riders are inexperienced, the researchers explained. They ... which has the highest number of motorcycle registrations in ... motorcyclist deaths. The analysis revealed a strong association ...
(Date:12/17/2014)... Dec. 16, 2014 (HealthDay News) -- Poor students get more ... a new study finds. But, the opposite is true ... having fruits and vegetables at school may give a healthy ... But, no matter what the family income level, students all ... the study found. The study was published recently in ...
(Date:12/17/2014)... Amy Norton HealthDay Reporter ... long been believed to improve overall health, but a growing ... the heart, a new review finds. In fact, the ... brisk walking, said lead researcher Paula Chu, a doctoral candidate ... review, of 37 clinical trials, found that people randomly assigned ...
(Date:12/15/2014)... researchers have just published an important new report on ... mesothelioma. Surviving Mesothelioma has just posted an article on ... read it now. , Doctors at Harvard, MIT, ... Langone Medical Center performed complete genetic analyses on 22 ... to pinpoint the genes that are most likely to ...
Breaking Medicine News(10 mins):Health News:Lice Troopers Announces New Lice Treatment Clinic in Coral Gables to Service Key Biscayne, Coconut Grove, Kendall, Brickell & South Miami 2Health News:When Gas Prices Go Up, So Do Motorcycle Accidents, Study Finds 2Health News:Poor Students Eat Healthier Foods at School, Study Finds 2Health News:Yoga May Cut Heart Disease Risk Factors 2Health News:Yoga May Cut Heart Disease Risk Factors 3Health News:New Study Reveals Genetic Mutations That May Trigger Mesothelioma, According to Surviving Mesothelioma 2
... vaccine is the first 5-in-1 pediatric combination for, immunization against ... ... b (Hib) -, SWIFTWATER, Pa. and LYON, France, June ... announced today,that the U.S. Food and Drug Administration (FDA) has ...
... AM ET MONDAY JUNE 23, 2008 , LOW SOCIOECONOMIC ... Cancer patients with low socioeconomic status (SES) have more advanced ... higher risk of dying in the five years following cancer ... appear in the August 1, 2008 issue of CANCER ...
... can prevent unnecessary accidents, experts say , , SUNDAY, June ... can greatly reduce the risk of serious head, spinal ... and recreational activities, says the American Association of Neurological ... head injuries treated in U.S. hospital emergency rooms in ...
... under 80, could ease expected worldwide shortfall of supplies , , ... called HBOC-201 proved safe and effective in a six-week Phase ... In all, 688 patients, ages 18 and older, who had ... (about one pint) or an equivalent one unit (65 grams) ...
... earlier treatment options for patients -, ... Millennium,Pharmaceuticals, The Takeda Oncology Company, and ... announced that the U.S. Food,and Drug Administration ... multiple myeloma (MM). The Company,s co-development partner,Johnson ...
... SAN FRANCISCO, June 20 The San Francisco,Medical Society ... in,Medical/Health Reporting." This $1,000 award is presented each ... good work of California reporters,from television, radio and ... 30, 2008 for the 2009 award., A ...
Cached Medicine News:Health News:U.S. FDA Licenses Sanofi Pasteur's New Pediatric Combination Vaccine, Pentacel(R) 2Health News:U.S. FDA Licenses Sanofi Pasteur's New Pediatric Combination Vaccine, Pentacel(R) 3Health News:U.S. FDA Licenses Sanofi Pasteur's New Pediatric Combination Vaccine, Pentacel(R) 4Health News:U.S. FDA Licenses Sanofi Pasteur's New Pediatric Combination Vaccine, Pentacel(R) 5Health News:Risk of death after cancer diagnosis; shift in stage of breast cancer diagnosis 2Health News:Risk of death after cancer diagnosis; shift in stage of breast cancer diagnosis 3Health News:Risk of death after cancer diagnosis; shift in stage of breast cancer diagnosis 4Health News:Risk of death after cancer diagnosis; shift in stage of breast cancer diagnosis 5Health News:Head Injuries All Too Common in Summer Play 2Health News:Blood Substitute Found Safe in Large Phase III Trial 2Health News:FDA Approves VELCADE(R) (Bortezomib) for Injection for Patients with Previously Untreated Multiple Myeloma 2Health News:FDA Approves VELCADE(R) (Bortezomib) for Injection for Patients with Previously Untreated Multiple Myeloma 3Health News:FDA Approves VELCADE(R) (Bortezomib) for Injection for Patients with Previously Untreated Multiple Myeloma 4Health News:FDA Approves VELCADE(R) (Bortezomib) for Injection for Patients with Previously Untreated Multiple Myeloma 5Health News:FDA Approves VELCADE(R) (Bortezomib) for Injection for Patients with Previously Untreated Multiple Myeloma 6Health News:SFMS David Perlman Award For Excellence in Medical/Health Reporting Recognizes Local Reporters 2
(Date:12/17/2014)... 2014 Los beneficios y ganancias ... nivel de gasto en investigación y desarrollo   ... 30 de septiembre de 2014) ZEISS aumentó sus ingresos ... euros (año anterior: 4.190 millones de euros) a pesar ... (EBIT) crecieron un 14 por ciento, a 360 millones ...
(Date:12/17/2014)... HOLBROOK, N.Y. , Dec. 17, 2014 /PRNewswire/ ... that The Depository Trust Company (DTC) has made ... the Deposit Chill on the Company,s stock effective ... of Northstar,s common stock for depository and book ... and the Company is now once again fully ...
(Date:12/17/2014)... MILAN , December 17, 2014 ... becoming nothing less than a hub of information concerning the ... A further addition to the recently launched ... world and has now been enriched by a new chapter ... A richly detailed and panoramic hub on ...
Breaking Medicine Technology:ZEISS confirma su posición en un entorno difícil 2Northstar announces that the DTC chill on MDIN has been officially lifted 2Northstar announces that the DTC chill on MDIN has been officially lifted 3Dompé Offers a New "Window" on the World of Scientific Research, with the http://www.dompetrials.com Website, Dedicated to Clinical Trials 2Dompé Offers a New "Window" on the World of Scientific Research, with the http://www.dompetrials.com Website, Dedicated to Clinical Trials 3
... CVS/pharmacy today announced the launch of Order ... program to receive immediate notification via text message ... up at over 7,300 CVS/pharmacy locations nationwide. ... "CVS/pharmacy,s new prescription Order Ready Text Messaging Program ...
... Feb. 1, 2012 Cardinal Health today announced the ... trays designed to help increase efficiencies and minimize waste ... The new trays include the essential clinical ... of time clinicians spend organizing supplies for procedures and ...
Cached Medicine Technology:CVS/pharmacy Helps Customers Save Time with New Prescription Text Alerts 2Cardinal Health Introduces Diagnostic Procedure Trays 2
... The Cholestech LDX System, using patented, innovative ... glucose and ALT in only 5 minutes ... ALT test, you can get immediate liver ... capabilities is not the only advantage to ...
The Strep A Rapid Test Strip is a rapid chromatographic,immunoassay for the qualitative detection of Strep A antigen,from throat swab specimens to aid in the diagnosis of Group A,Streptococcal ...
SAS Strep A Test is a rapid visual test for the presumptive qualitative detection of Group A Streptococcal antigen from throat swab specimens. Group A streptococcus is the principal cause of respirat...
HemataSTAT II has a manual reader. It uses both 0.5 and 1.1 ID capillary tubes., , Spins in just 60 seconds , Built-in reader with LCD display , Accuracy comparable to NCCLS reference method , Lid lo...
Medicine Products: